Updates in Pharmacology Characterization of PF-6142, a Novel, Non-Catecholamine Dopamine Receptor D1 Agonist, in Murine and Nonhuman Primate Models of Dopaminergic ActivationDownload Characterization-of-PF-6142-a-Novel-Non-Catecholamine-Dopamine-Receptor-D1-Agonist-in-Murine-and-Nonhuman-Primate-Models-of-Dopaminergic-Activation Share: Newer Post Venetoclax in the Treatment of Chronic Lymphocytic Leukemia: Evidence, Expectations, and Future Prospects Older Post Lapatinib Activates the Kelch-Like ECH-Associated Protein 1-Nuclear Factor Erythroid 2-Related Factor 2 Pathway in HepG2 Cells